ELTROMBOPAG OLAMINE

Biocon Pharma became the applicant for eltrombopag olamine NDA 220660, replacing Aizant as the listed sponsor.

Biocon Pharma Ltd replaced Aizant Drug Research Solutions Private Ltd as the applicant for eltrombopag olamine (NDA 220660, supplement 004).

Biocon Pharma replaced Aizant as the applicant for eltrombopag olamine (NDA 220660, Supplement 003).

Applicant for eltrombopag olamine (NDA 220660) changed from AIZANT to BIOCON PHARMA.

Biocon Pharma acquired applicant responsibility for eltrombopag olamine (NDA 220660), replacing Aizant as the listed manufacturer.

Biocon Pharma Ltd acquired or assumed responsibility for NDA 220660 (eltrombopag olamine), replacing Aizant Drug Research Solutions Private Ltd as the listed applicant.

Biocon Pharma Ltd acquired or assumed ownership of NDA 220660 for eltrombopag olamine (applicant name changed from Aizant Drug Research Solutions Private Ltd).

Biocon Pharma Ltd replaced Aizant Drug Research Solutions Private Ltd as the listed applicant for Eltrombopag Olamine (NDA 220660).